Stock Analiz

Cellebrite DI Ltd. (CLBT) financials: revenue, earnings and cash flow

Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Cellebrite DI’s revenue went from $172M in fiscal 2019 to $476M in fiscal 2025, growth of about 18.5% a year.

Net income in fiscal 2025 was $78M, a net margin of 16.5%; the best year in this period was 2022 with $121M.

Over the twelve months to September 30, 2026, revenue was $537M and net income $65M.

Free cash flow was $160M in fiscal 2025 and positive in 7 of the 7 years shown.

Revenue, profit and cash flow by year

Revenue
2019: $172M20192020: $195M20202021: $246M20212022: $271M20222023: $325M20232024: $401M20242025: $476M2025$476M
Net income
2019: -$2M20192020: $6M20202021: $71M20212022: $121M20222023: -$81M20232024: -$283M20242025: $78M2025$78M
Free cash flow
2019: $10M20192020: $60M20202021: $31M20212022: $14M20222023: $97M20232024: $124M20242025: $160M2025$160M
EPS (diluted)
2019: $-0.0120192020: $0.0220202021: $0.2820212022: $0.4820222023: $-0.3220232024: $-1.1320242025: $0.312025$0.31

Income statement

Fiscal yearTTM2025202420232022202120202019
Revenue$537M$476M$401M$325M$271M$246M$195M$172M
Gross profit—$401M$339M$272M$220M$204M$157M$136M
Operating income—$66M$57M$33M$1M$14M$9M-$2M
Net income$65M$78M-$283M-$81M$121M$71M$6M-$2M
EPS (diluted)$0.26$0.31$-1.13$-0.32$0.48$0.28$0.02$-0.01
R&D—$114M$98M$84M$81M$66M$54M$47M
Revenue growth—+18.6%+23.4%+20.1%+9.9%+26.3%+13.4%—

Cash flow

Fiscal yearTTM2025202420232022202120202019
Operating cash flow$181M$174M$132M$102M$21M$36M$67M$16M
Capital spending-$39M-$13M-$9M-$5M-$7M-$5M-$6M-$6M
Free cash flow$142M$160M$124M$97M$14M$31M$60M$10M
Dividends paid———$0$0$100M$10M$25M
Buybacks————$0$0$85000$808000
Stock-based pay—$45M$31M$19M$14M$6M$7M$13M

Balance sheet

Fiscal yearTTM2025202420232022202120202019
Cash—$276M$293M$228M$132M$146M$134M$82M
Debt—$23M$11M$14M$15M$18M$0—
Equity—$484M$336M$34M$74M-$73M$64M$59M
Total assets—$939M$691M$533M$403M$340M$364M—
Shares (diluted)253M251M251M251M251M251M251M251M

Margins and returns

Fiscal yearTTM2025202420232022202120202019
Gross margin—84.2%84.4%83.6%81.2%82.7%80.6%79.1%
Operating margin—14.0%14.2%10.2%0.4%5.6%4.7%-0.9%
Net margin12.0%16.5%-70.5%-24.9%44.6%29.0%3.0%-1.1%
FCF margin26.4%33.7%30.8%29.8%5.1%12.6%30.9%5.8%
ROIC—11.3%13.0%54.3%0.9%—7.3%-2.0%
ROE—16.2%-84.2%-237.0%163.5%-97.3%9.1%-3.2%

Frequently asked questions

What is Cellebrite DI’s annual revenue?

$476M in fiscal 2025 and $537M over the twelve months to September 30, 2026.

How much profit does Cellebrite DI make?

Net income was $78M in fiscal 2025 (net margin 16.5%).

Is Cellebrite DI’s revenue growing?

Yes: revenue rose 18.6% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.